PA9159 Metered-Dose Inhaler, 120 μg per day for 28 days

DRUG2 trials

Sponsors

Anhui Palo Alto Pharmaceuticals, Inc.

Conditions

Bronchial Asthma

Phase 2

Study on the Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma

RecruitingNCT07324707

Anhui Palo Alto Pharmaceuticals, Inc.Bronchial Asthma

Start: 2025-10-15End: 2026-03-31Target: 30Updated: 2026-01-07

Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthma

RecruitingNCT07326995

Anhui Palo Alto Pharmaceuticals, Inc.Bronchial Asthma

Start: 2025-02-24End: 2026-03-31Target: 60Updated: 2026-01-08